Monoclonal antibody AER002 fails to ease Long COVID symptoms in first randomized mechanistic trial ↗
Monoclonal antibody AER002 fails to ease Long COVID symptoms in first randomized mechanistic trial Bioengineer.org
Automatisch gemaakte samenvatting (AI), kan fouten bevatten. Lees de bron.